z-logo
Premium
ATP, a partial agonist for the P2Z receptor of human lymphocytes
Author(s) -
Gargett Caroline E.,
Cornish Jean E.,
Wiley James S.
Publication year - 1997
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701447
Subject(s) - agonist , adenosine triphosphate , biophysics , extracellular , receptor , biology , microbiology and biotechnology , chemistry , biochemistry
1 Although extracellular adenosine 5′‐triphosphate (ATP) is the natural ligand for the P2Z receptor of human lymphocytes it is less potent than 3′‐ O ‐(4‐benzoylbenzoyl)‐ATP (BzATP) in opening the associated ion channel, which conducts a range of permeants including Ba 2+ and ethidium + . We have quantified the influx of ethidium + into lymphocytes produced by BzATP, ATP, 2‐methylthio‐ATP (2MeSATP) and ATPγS, studied competition between ATP and BzATP and investigated the effects of KN‐62, a new and potent inhibitor of the P2Z receptor. 2 BzATP and ATP stimulated ethidium + influx with EC 50 values of 15.4±1.4 μ M ( n =5) and 85.6±8.8 μ M ( n =5), respectively. The maximal response to ATP was only 69.8±1.9% of that for BzATP. Hill analysis gave n H of 3.17±0.24 ( n =3) and 2.09±0.45 ( n =4) for BzATP and ATP, suggesting greater positive cooperativity for BzATP than for ATP in opening the P2Z receptor‐operated ion channel. 3 A rank order of agonist potency of BzATP>ATP=2MeSATP>ATPγS was observed for agonist‐stimulated ethidium + influx, while maximal influxes followed a rank order of BzATP>ATP>2MeSATP>ATPγS. 4 Preincubation with 30–50 μ M oxidized ATP (ox‐ATP), an irreversible P2Z inhibitor, reduced the maximal response but did not change the steepness of the Ba 2+ influx‐response curve produced by BzATP (n H 3.2 and 2.9 for 30 and 50 μ M ox‐ATP, respectively ( n =2)). 5 ATP (300–1000 μ M ) added simultaneously with 30 μ M BzATP (EC 90 ) inhibited both ethidium + and Ba 2+ fluxes to a maximum of 30–40% relative to the values observed with BzATP alone. Moreover, ATP (300 μ M ) shifted the concentration‐response curve to the right for BzATP‐stimulated Ba 2+ influx, confirming competition between ATP and BzATP. 6 KN‐62, a new and powerful inhibitor of the lymphocyte P2Z receptor, showed less potency in antagonizing BzATP‐mediated fluxes than ATP‐induced fluxes when maximal concentrations of both agonists (BzATP, 50 μ M ; ATP, 500 μ M ) were used. 7 These data suggest that the natural ligand, ATP, is a partial agonist for the P2Z receptor while BzATP is a more efficacious agonist. Moreover the competitive studies show that only a single class of P2‐receptor (P2Z class) is expressed on human leukaemic lymphocytes.British Journal of Pharmacology (1997) 122 , 911–917; doi: 10.1038/sj.bjp.0701447

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom